Arriva Pharmaceuticals, Inc.
Records under this name other than patents Arriva Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Arriva Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,914,771 | Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor Lapsed on the fee record Ended Mar 29, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 29, 2019 | From the USPTO record |
| US 7,892,825 | Method of protein production in yeast Lapsed on the fee record Ended Feb 22, 2019 · From the USPTO record | Lapsed on the fee record | Ended Feb 22, 2019 | From the USPTO record |
| US 7,709,446 | Multifunctional protease inhibitors and their use in treatment of disease Lapsed on the fee record Ended May 4, 2014 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2014 | From the USPTO record |
| US 7,419,801 | Methods of protein production in yeast Lapsed on the fee record Ended Sep 2, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 2, 2012 | From the USPTO record |
| US 7,247,704 | Multifunctional protease inhibitors and their use in treatment of disease Lapsed on the fee record Ended Jul 24, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jul 24, 2011 | From the USPTO record |